These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 20219041

  • 1. Faecal calprotectin concentrations in children with functional gastrointestinal disorders diagnosed according to the Pediatric Rome III criteria.
    Flagstad G, Helgeland H, Markestad T.
    Acta Paediatr; 2010 May; 99(5):734-737. PubMed ID: 20219041
    [Abstract] [Full Text] [Related]

  • 2. Diagnosing pediatric functional abdominal pain in children (4-15 years old) according to the Rome III Criteria: results from a Norwegian prospective study.
    Helgeland H, Flagstad G, Grøtta J, Vandvik PO, Kristensen H, Markestad T.
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):309-15. PubMed ID: 19525874
    [Abstract] [Full Text] [Related]

  • 3. Paediatric Rome III Criteria-Related Abdominal Pain Is Associated With Helicobacter pylori and Not With Calprotectin.
    Sýkora J, Huml M, Siala K, Pomahačová R, Jehlička P, Liška J, Kuntscherová J, Schwarz J.
    J Pediatr Gastroenterol Nutr; 2016 Oct; 63(4):417-22. PubMed ID: 26913755
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R.
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [Abstract] [Full Text] [Related]

  • 5. Faecal calprotectin in children with chronic gastrointestinal symptoms.
    Bremner A, Roked S, Robinson R, Phillips I, Beattie M.
    Acta Paediatr; 2005 Dec; 94(12):1855-8. PubMed ID: 16421055
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
    Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):615-21. PubMed ID: 15352909
    [Abstract] [Full Text] [Related]

  • 7. [Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease].
    Bonnín Tomàs A, Vila Vidal M, Rosell Camps A.
    Rev Esp Enferm Dig; 2007 Dec 15; 99(12):689-93. PubMed ID: 18290691
    [Abstract] [Full Text] [Related]

  • 8. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.
    Xiong LS, Shi Q, Gong XR, Cui Y, Chen MH.
    J Dig Dis; 2014 Oct 15; 15(10):538-44. PubMed ID: 25102919
    [Abstract] [Full Text] [Related]

  • 9. Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey.
    Hestvik E, Tumwine JK, Tylleskar T, Grahnquist L, Ndeezi G, Kaddu-Mulindwa DH, Aksnes L, Olafsdottir E.
    BMC Pediatr; 2011 Feb 02; 11():9. PubMed ID: 21284894
    [Abstract] [Full Text] [Related]

  • 10. Effect of faecal calprotectin testing on referrals for children with chronic gastrointestinal symptoms in primary care: study protocol for a cluster randomised controlled trial.
    Ansems S, Berger M, Rheenen PV, Vermeulen K, Beugel G, Couwenberg M, Holtman G.
    BMJ Open; 2021 Jul 23; 11(7):e045444. PubMed ID: 34301652
    [Abstract] [Full Text] [Related]

  • 11. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T, Kolho KL.
    Scand J Gastroenterol; 2010 Aug 23; 45(7-8):872-7. PubMed ID: 20377469
    [Abstract] [Full Text] [Related]

  • 12. Symptomatic Treatment of Pain-Related Pediatric Functional Gastrointestinal Disorders in a Biopsychosocial Construct, and a Validity Study of Rome III Criteria.
    Madani S, Madani R, Parikh S, Manivannan A, Orellana WR, Thomas R, Di Lorenzo C.
    Clin Pediatr (Phila); 2021 Jun 23; 60(6-7):304-313. PubMed ID: 33973488
    [Abstract] [Full Text] [Related]

  • 13. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
    Van de Vijver E, Schreuder AB, Cnossen WR, Muller Kobold AC, van Rheenen PF, North Netherlands Pediatric IBD Consortium.
    Arch Dis Child; 2012 Dec 23; 97(12):1014-8. PubMed ID: 23019289
    [Abstract] [Full Text] [Related]

  • 14. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.
    Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, Beglinger C, Lehmann FS.
    BMC Gastroenterol; 2012 Jan 10; 12():5. PubMed ID: 22233279
    [Abstract] [Full Text] [Related]

  • 15. Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.
    Walker GJ, Moore L, Heerasing N, Hendy P, Perry MH, McDonald TJ, Debenham T, Bethune R, Bewshea C, Hyde C, Heap GA, Singh A, Calvert C, Kennedy NA, Goodhand JR, Ahmad T.
    Aliment Pharmacol Ther; 2018 Apr 10; 47(8):1103-1116. PubMed ID: 29508423
    [Abstract] [Full Text] [Related]

  • 16. The use of fecal calprotectin as a biomarker in gastrointestinal disease.
    Burri E, Beglinger C.
    Expert Rev Gastroenterol Hepatol; 2014 Feb 10; 8(2):197-210. PubMed ID: 24345070
    [Abstract] [Full Text] [Related]

  • 17. Rome II versus Rome III classification of functional gastrointestinal disorders in pediatric chronic abdominal pain.
    Baber KF, Anderson J, Puzanovova M, Walker LS.
    J Pediatr Gastroenterol Nutr; 2008 Sep 10; 47(3):299-302. PubMed ID: 18728525
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Validation of the Rome III criteria and alarm symptoms for recurrent abdominal pain in children.
    Gijsbers CF, Benninga MA, Schweizer JJ, Kneepkens CM, Vergouwe Y, Büller HA.
    J Pediatr Gastroenterol Nutr; 2014 Jun 10; 58(6):779-85. PubMed ID: 24866784
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.